Major American medical group drops opposition to euthanasia
by Xavier Symons | 20 Oct 2018 |
One of America’s largest medical associations has dropped its long standing opposition to euthanasia, voting at a national meeting to instead adopt a position of “engaged neutrality”. The American Academy of Family Physicians (AAFP) represents doctors who specialise in family medicine, and has over 131,000 members.
At the Academy’s 2018 Congress of Delegates in New Orleans earlier this month, over two-thirds of delegates voted to change the position, with several representatives giving impassioned speeches about how the availability of euthanasia could help ease the suffering of patients.
The new resolution passed by the delegates also calls on the AAFP to reject use of the phrase "assisted suicide" or "physician-assisted suicide" in its own formal communications and to direct the Academy's delegation to the AMA to promote the same action in the House of Delegates. The term preferred by the academy's representatives is "medical aid in dying".
Dr. Barbara Golder, a board member of the Catholic Medical Association and editor-in-chief of its Linacre Quarterly, was critical of the AAFP’s decision. She said the move was “very, very disappointing” but should not necessarily be considered a full victory for backers of assisted suicide.
“Some people will want to look on this as a great achievement in terms of advancing physician-assisted suicide, and it certainly puts us on a slippery slope, but I think it’s also important to recognize that the AAFP did not endorse it,” Golder said.
The leading bioethics issue in American politics is, by far, abortion. But others have made an impact. The proper use of human embryonic stem cells was debated in Obama’s first campaign. Euthanasia is sure to become an issue at some stage. But, much to my surprise, consumer genetics is emerging as a sleeper issue.
Millions of Americans have used the services of direct-to-consumer genetic ancestry testing companies. Now Senator Elizabeth Warrane, aka “Pocahontas” to supporters of President Trump, has resorted to one to settle the controversial question of her Native American heritage. A report has finally demonstrated that she may have had a Native American ancestor six to ten generations ago. But it does not demonstrate that this ancestor was from the Cherokee tribe, or even from a tribe in the United States.
Settling questions of personal identity with genetics is fraught with uncertainty. It’s an area that politicians – and everyone else -- should approach with great caution.
Millions of Americans have used the services of direct-to-consumer genetic ancestry testing companies. Now Senator Elizabeth Warrane, aka “Pocahontas” to supporters of President Trump, has resorted to one to settle the controversial question of her Native American heritage. A report has finally demonstrated that she may have had a Native American ancestor six to ten generations ago. But it does not demonstrate that this ancestor was from the Cherokee tribe, or even from a tribe in the United States.
Settling questions of personal identity with genetics is fraught with uncertainty. It’s an area that politicians – and everyone else -- should approach with great caution.
Michael Cook Editor BioEdge |
NEWS THIS WEEK
by Michael Cook | Oct 21, 2018
Victim of Trump’s ‘Pocahontas’ gibe takes genetic test by Michael Cook | Oct 21, 2018
Doctor who refused to insert IUDs vindicated by Michael Cook | Oct 21, 2018
Posthumous essays reveal his fear of genetic ‘improvements’ by Xavier Symons | Oct 20, 2018
Officials say 31 studies should be retracted. by Xavier Symons | Oct 20, 2018
The Academy of Family Physicians has adopted a position of "engaged neutrality". by Xavier Symons | Oct 20, 2018
UK GPs will be encouraged to refer patients to social activities. by Xavier Symons | Oct 20, 2018
Many are concerned that we are not adequately prepared. by Michael Cook | Oct 20, 2018
Was it really over a few copied sentences? BioEdge
Suite 12A, Level 2 | 5 George St | North Strathfield NSW 2137 | Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615
No hay comentarios:
Publicar un comentario